Cargando…

Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract

Using preclinical models, we have recently found that ELK1, a transcriptional factor that activates downstream targets, including c-fos proto-oncogene, induces bladder cancer outgrowth. Here, we immunohistochemically determined the expression status of phospho-ELK1, an activated form of ELK1, in upp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Satoshi, Ide, Hiroki, Fujita, Kazutoshi, Mizushima, Taichi, Jiang, Guiyang, Kawahara, Takashi, Yamaguchi, Seiji, Fushimi, Hiroaki, Nonomura, Norio, Miyamoto, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877638/ https://www.ncbi.nlm.nih.gov/pubmed/29518027 http://dx.doi.org/10.3390/ijms19030777

Ejemplares similares

NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract
por: Kawahara, Takashi, et al.
Publicado: (2017)

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2018)

ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
por: Inoue, Satoshi, et al.
Publicado: (2018)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2020)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
por: Kashiwagi, Eiji, et al.
Publicado: (2018)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression
por: Kawahara, Takashi, et al.
Publicado: (2015)

FOXO1 inactivation induces cisplatin resistance in bladder cancer
por: Ide, Hiroki, et al.
Publicado: (2020)

Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

Fragmentation of cell‐free DNA is induced by upper‐tract urothelial carcinoma–associated systemic inflammation
por: Nakano, Kosuke, et al.
Publicado: (2020)

The Role of Steroid Hormone Receptors in Urothelial Tumorigenesis
por: Ide, Hiroki, et al.
Publicado: (2020)

Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma
por: Nakano, Kosuke, et al.
Publicado: (2022)

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2019)

Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor
por: Ide, Hiroki, et al.
Publicado: (2015)

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
por: Jiang, Guiyang, et al.
Publicado: (2021)

Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters()()
por: Yoshida, Takahiro, et al.
Publicado: (2015)

MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2017)

Application of Anti-Inflammatory Agents in Prostate Cancer
por: Hatano, Koji, et al.
Publicado: (2020)

Influence of Diet and Nutrition on Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2020)

The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells
por: Li, Peng, et al.
Publicado: (2018)

ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion
por: Kawahara, Takashi, et al.
Publicado: (2016)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
por: Hayashi, Takuji, et al.
Publicado: (2019)

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
por: Hayashi, Takuji, et al.
Publicado: (2016)

Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
por: Teramoto, Yuki, et al.
Publicado: (2021)

Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2012)

Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
por: Park, Bong Hee, et al.
Publicado: (2013)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

The Role of Androgen Receptor Signaling in Ovarian Cancer
por: Mizushima, Taichi, et al.
Publicado: (2019)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
por: Tanaka, N, et al.
Publicado: (2012)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Time to change the management of upper urinary tract urothelial carcinoma
por: Akand, Murat, et al.
Publicado: (2020)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pd714uhgpof0g7nanf39kpe127